Costimulatory pathways in multiple sclerosis
Costimulatory molecules can be categorized based either on their functional attributes or on their structure. The costimulatory molecules discussed in this review will be divided into (1) positive costimulatory pathways: promoting T cell activation, survival and/or differentiation; (2) negative costimulatory pathways:antagonizing TCR signalling and suppressing T cell activation; (3) as third group we will discuss the members of the TIM family, a rather “new” family of cell surface molecules involved in the regulation of T cell differentiation and Treg function. Costimulatory pathways have a critical role in the regulation of alloreactivity. A complex network of positive and negative pathways regulates T cell responses. Blocking costimulation improves allograft survival in rodents and non-human primates. The costimulation blocker belatacept is being developed as immunosuppressive drug in renal transplantation.
Related Conference of Costimulatory pathways in multiple sclerosis
Costimulatory pathways in multiple sclerosis Conference Speakers
Recommended Sessions
- Allergy and Therapies
- Antigen Processing
- Autoimmunity and Therapeutics
- Cancer and Tumor Immunobiology
- Cellular Adhesion
- Clinical and Cellular Immunology
- Clinical Immunology
- Costimulatory pathways in multiple sclerosis
- Diagnostic Immunology
- Hematopoiesis and Immune System Development
- Immune Response Regulation, Molecular Mechanisms
- Immunodeficiencies
- Immunoinformatics and Systems Immunology
- Immunopathology
- Immunotherapy
- Infectious Diseases and Immune System
- Inflammatory/Autoimmune Diseases
- Innate Immune Responses
- Microbial, Parasitic, and Fungal Immunology
- Neuro Immunology
- Reproductive Immunology
- T-Cells and B-Cells
- Technological Innovations in Immunology
- Transplantation Immunology
- Vaccines and Vaccination
- Viral Immunology
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)

